There is great geographical variation in the distribution of hepatocellular carcinoma (HCC),
with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one …

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

This guidance provides a data-supported approach to the diagnosis, staging, and treatment
of patients diagnosed with hepatocellular carcinoma (HCC). A guidance document is …

Purpose Data guiding selection of nonsurgical treatment of hepatocellular carcinoma (HCC)
are lacking. We therefore compared outcomes between stereotactic body radiotherapy …

Purpose To evaluate the efficacy and safety of high-dose, hypofractionated proton beam
therapy for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) …

Several recent developments in linear accelerator–based radiation therapy (RT) such as fast
multileaf collimators, accelerated intensity modulation paradigms like volumeric modulated …

Background and purpose Stereotactic body radiotherapy (SBRT) is an emerging ablative
modality for hepatocellular carcinoma (HCC). This study aimed to synthesize available …

Purpose To conduct a large single-institution comparison of transarterial chemoembolization
(TACE) and stereotactic body radiation therapy (SBRT) outcomes in similar groups of …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Segmentation of normal organs is a critical and time-consuming process in radiotherapy.
Auto-segmentation of abdominal organs has been made possible by the advent of the …